The Mesothelioma Applied Research Foundation is pleased to announce the addition of six new members to its Board of Directors (BOD) and six new members to its Science Advisory Board (SAB). The two boards are tasked with governing the organization and overseeing the organization’s research grants program, respectively.
“We are inspired by the talent and credentials of the members of our governing board and our Science Advisory Board. I look forward to working with them to promote the mission of this Foundation,” said Mary Hesdorffer, nurse practitioner and executive director of the Mesothelioma Applied Research Foundation.
The Meso Foundation’s BOD assumes responsibility for ensuring the organization’s long-term financial stability and integrity and – through consensus and majority vote with the other members – for governing the organization and setting its strategic direction and broad policy directives. A full list of members can be found on the Foundation’s website.
New members of the BOD include:
- Keith Cengel, MD, PhD – University of Pennsylvania
- Patrick Forde, MBBCh – Johns Hopkins
- Buerkley Rose, RN – The University of Chicago
- Daniel Sterman, MD – New York University
- James Stevenson, MD – Cleveland Clinic
- Antoinette Wozniak, MD – University of Pittsburgh Medical Center
New members of the SAB include:
- Joseph Friedberg, MD – University of Maryland
- Travis Grotz, MD – Mayo Clinic
- Chuong D. Hoang, MD – National Institutes of Health (NIH)
- Fabian Johnston, MD, MHS – Johns Hopkins
- Steve Mutsaers, PhD – University of Western Australia
- Emanuela Taioli, MD, PhD – Mount Sinai
The Mesothelioma Applied Research Foundation is the only 501(c)(3) nonprofit organization working to eradicate mesothelioma and end this national tragedy. Its programs include the funding of promising and peer-reviewed research, education, support and advocacy. The organization strives to bring together thought-leaders in the field to identify the most direct path to a cure.
